drugset / Trial / NCT01402479
An Open-labeled Trial of Ramipril in Patients With Migraine
Non-randomizedSingle-groupOpen-labelTreatment
Summary
Physiology of migraine involving renin-angiotensin systems (RAS) has been implicated. Ramipril is a broadly-used angiotensin-converting enzyme inhibitor. The investigators attempt to test the efficacy of ramipril on the prophylaxis of migraine attacks.
Timeline
- Start
- 2004-10
- Primary completion
- 2005-07
- Completion
- 2005-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Ramipril | Small molecule | 2.5 mg | — |